Mutational analyses in xenopus oocyte and mice models indicate that the positive effect of nicotine on attention may be modulated by genetic variations within exon 5 of the alpha4 subunit of the nicotinergic acetylcholine receptor gene CHRNA4. The potential relevance of exon 5 is further emphasized by two recent family-based association studies of nicotine dependence because subgroups of nicotine-dependent subjects are thought to "selfmedicate" attentional deficits with nicotine. We investigated a synonymous single nucleotide polymorphisms (SNP): rs1044396, which has recently been associated with nicotinedependence, plus two adjacent synonymous SNPs rs1044394 and rs1044393 in exon 5 of N=47 unrelated healthy Caucasian subjects (age: 22.7±1.7 yrs.; sex: N = 23 males; regular smokers: N=19). Attentional network function was assessed in supplementary motor area/anterior cingulate (SMA/ACC) and parietal cortex with functional magnetic resonance imaging (fMRI) during an attention-requiring visual oddball task. SNP rs1044396 showed genotype effects on attentional network function both in the SMA/ACC and parietal cortex in the absence of overt behavioral effects. In the parietal cortex, a gene-dosage effect was seen.
INTRODUCTION
(restriction fragment length polymorphism) were reported to show reduced vigilance and to be more sensitive to the effects of nicotine on Y-maze crossing and rearing activities (33). In mutant mice, α4 nicotinic subunits containing a single point mutation in the pore-forming second transmembrane domain (M2) were found to render the α4 receptors hypersensitive to nicotine (34) . There are also several reports of a possible association of cognitive deficits ("mental retardation") with a missense mutation in exon 5 that replaces a serine into phenylalanine in CHRNA4 which in turn affects the M2 domain of the receptor (35-36). Using patch clamp, it has been previously demonstrated in the xenopus oocyte model that this missense mutation in exon 5 induces distinct modifications of the receptor´s (ion channel) functional properties including a significant increase in acetylcholine sensitivity (37). It is therefore of particular interest that two large family-based studies of male Chinese (38) and European-American subjects (39) have associated measures of nicotine dependence with single nucleotide polymorphisms (SNPs) within exon 5 of CHRNA4. This is because it is conceivable that genetic variations in exon 5 may affect nicotine receptor sensitivity and -by extension -attentional network function which in turn may promote in a subgroup of smokers the intiation and maintenance of nicotine abuse for reasons of self-medication of attentional deficits.
It was the purpose of the present study to address the question whether genetic variation within exon 5 of CHRNA4 are associated with attentional network function as assessed with functional magnetic resonance imaging (fMRI).
In subsequently conducted VOI analyses in both regions, no statistically significant effects of smoking status (regular smoker vs. non-smokers) were seen on BOLD-response (bihemispheric SMA/ACC: F = 0.7; df = 1, 45; P = 0.419; left parietal cortex: F = 0.0; df = 1, 45; P = 0.962) when using smoking status as fixed factor and the BOLD-response (mean Zvalue) as dependent variable. Likewise, no signficant effects of smoking status were observed when instead using the number of "activated" voxels (BOLD-response threshold: Z > 2. 3 We also did not further take into consideration "years of education" because no significant correlations were seen with VOI mean Z-value bihemispheric SMA/ACC BOLDresponse (R = -0.03; P = 0.861) or with VOI mean Z-value left parietal BOLD-response (R = -0.21; P = 0.184). On the other hand, attentional network BOLD-response differences were found between males and females -the latter showing stronger BOLD-responses both in the bihemispheric SMA/ACC and left parietal cortex -although these differences just missed statistical significance. SMA/ACC (mean Z-value): males = 0.41±0.60, females = 0.72±0.65; t = -1.7; P = 0.100), SMA/ACC (n of voxels Z > 2.3): males = 18.3±39.5, females = 43.8±61.2; t = -1.7; P = 0.099), left parietal cortex (mean Z-value): males = 0.44±0.85, females = 0.96±1.04; t = -1.9, P = 0.068), left parietal cortex (n of voxels Z > 2.3): males = 18.5±40.5, females = 52.1±78.7; t = -1.8, P = 0.074). Therefore, we included sex as a covariate into the subsequently conducted statistical calculations.
Mean reaction time or mean intrasubject reaction time varibility was not significantly correlated with the mean Z-value (BOLD-response) in the selected VOIs (data not depicted).
However, non-significant trend correlations were observed for all three VOIs (left and right medial frontal, left parietal) with mean reaction time (P < 0.10). These correlations were negative indicating stronger attentional network activation in those subjects with shorter reaction time which is in line with previous reports from our group (41).
Attentional network function and genotype
In Figure 2 , separate voxel-by-voxel analyses are presented for each genotype group (rs1044396). Differences of BOLD-responses become apparent between genotype groups both in SMA/ACC and parietal cortex. The strongest BOLD-response was seen in A/A carriers. In comparison, A/G carriers showed a diminished BOLD-response -particularly in SMA/ACC. Virtually no activity was detected in G/G carriers. BOLD-response differences between genotype goups are confimed by a voxel-wise group contrast between A/A and G/G carriers ( Figure 3 ). In the contrast analyses of homozygous carriers, the peak activation maximum genotype group differences were seen in the left ACC/SMA with Z = 2.9 at -4, -16, 52mm and in the left parietal cortex with Z = 3.7 at -54, -16, 12mm.
A subsequently conducted VOI-analysis of the SMA/ACC brain region ( Figure 4) showed a significant main effect of genotype (rs1044396) on attentional network function in SMA/ACC with genotype as fixed factor, sex as covariate and SMA/ACC BOLD-response (mean VOI Z-value) as dependent variable (F = 3.4; df = 2, 43; P = 0.042). When instead using the number of "activated" voxels (BOLD-response threshold: Z > 2.3) as dependent variable, no significant effect was seen (F = 0.9; df = 2, 43; P = 0.411). An additionally conducted separate mean Z-value VOI-analysis of the genotype effects in left and right SMA/ACC showed that the genotype effect on medial prefrontal BOLD-response was somewhat stronger in the right hemisphere (F = 3.8; df = 2, 43; P = 0.029) than in the left hemisphere (F = 1.9; df = 2, 43; P = 0.159).
Similar results were obtained for the left parietal cortex VOI ( Figure 5 ), although now a clear gene-dosage effect became apparent: a significant main effect of genotype (rs1044396) was seen on left parietal network function with genotype as fixed factor, sex as covariate and left parietal BOLD-response (mean VOI Z-value) as dependent variable (F = 3.3; df = 2, 43; P = 0.047). When instead using the number of "activated" voxels (BOLD-response threshold: Z > 2.3) as dependent variable, statistical significance was missed (F = 2.9; df = 2, 43; P = 0.068).
A significant main effect was also observed for the adjacent SNP rs1044394 (F = 5.1; df = 1, 45; P = 0.024) on the mean Z-value BOLD-response in SMA/ACC VOI which was again stronger for the right hemispheric VOI (F =9.7; df = 1, 45; P = 0.003) than for the left hemispheric VOI (F =0.3; df = 1, 45; P = 0.622). On the other hand, a corresponding genotype effect was not seen for the left parietal region (F = 1.2; df = 1, 45; P = 0.277).
However, the number of heterozygous carriers was small (N = 7) as compared to homozygous carriers (N = 40). Likewise, a significant main effect was seen for SNP rs1044393 on SMA/ACC BOLD-response (F = 4.6; df = 1, 45; P = 0.037). An additionally conducted separate analysis of the left and right VOI in SMA/ACC revealed that the genotype effect on BOLD-response was again stronger in the right hemisphere (F = 5.2; df = 1, 43; P = 0.027) than in the left hemisphere (F = 0.4; df = 1, 43; P = 0.522). Again, however, no comparable genotype effect was found for the left parietal region (F = 0.9; df = 1, 45; P = 0.355).
DISCUSSION
Our investigation provides first evidence that attentional network function in humans may be modulated by genetic variations within CHRNA4 exon 5. The results are intriguing because 1) mutational analyses in mouse and oocyte models have indicated that exon 5 may be critical for proper function of the high-affinity alpha4beta2 nicotine receptor (34, 37), nicotine is well known to impact on attentional network function (1-23) and 3) genetic variations of CHRNA4 exon 5 have been implicated in nicotine dependence (38, 39).
Accordingly, our findings are in agreement with our original notion that genetic variations in There is further evidence from several sides that CHRNA4 exon 5 may indeed play a role in several neuropsychiatric disorders. Scheffer et al. (46) described an inherited form of a artial epilepsy that they termed autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE). So far, six different mutations have been identified in ADNFLE, four of them are located in CHRNA4 and two in CHRNB2 (36, 37, 47, 48). These mutations do not seem to lead to any gross abnormalities; the patients have normal neurological examination, magnetic resonance scans mostly reveal no pathology and interictal EEGs are often normal. Picard et al. (49) described 71 patients from 19 families with three different types of autosomal dominant partial epilepsies and screened them for a history of psychiatric disturbances. They found that behavioural disorders were most common in the ADNFLE (43%), compared with familial temporal lobe epilepsy (13%) and partial epilepsy with variable foci (23%). As there has been a considerable interest in the association between epilepsy and schizophrenia/psychosis for many decades (50), the high frequency of psychiatric diagnoses among patients with ADNFLE may not be an artefact. Actually, in one recent study of an ADNFLE family the affected members who carried an insertion of an additional leucine (776ins3) in exon 5 of the CHRNAA4 gene were found to have an unusual high rate of serious psychiatric disorders with mostly psychosis or schizophrenia-like clinical features (51). In addition, there are several reports of a possible association of cognitive deficits ("mental retardation") and a missense mutation in exon 5 that replaces a serine into phenylalanine in CHRNA4 (35, 36). In conclusion, it is possible that nAChR mutations might be a rare cause of schizophrenia even in patients without epilepsy. A less spectacular but more frequent mechanism may involve a contribution of certain nAChR gene variants to schizophrenia susceptibility. In such a model common gene variants would subtly alter the function of the nAChR, conferring a susceptibility effect to the genetically complex predisposition of schizophrenia. Such genetic effects can manifest themselves in different phenotypic aspects and their detection therefore requires a careful clinical characterisation of the patient samples (e.g. attentional capacity and network activity).
While the findings in ADNFLE families suggest a possible link between variations in the CHRNA4 (and CHRNB2) genes and schizophrenia rsp. cognitive deficits (broadly defined), there are also reports that indicate a relationship with attention deficit disorder. For instance, a recent family-based association study (52) , which systematically screened for sequence variations in the coding regions as well as intron/exon junctions of the α4 subunit, found a significant association for a 5´ intron 2 SNP and severe attentional problems. The 
Behavioral task
Before the experiment, smokers were allowed to smoke ad libidum and imaging was conducted after approximately one hour of nicotine abstinence. Thus, we expected acute nicotine effects to be minimal from prior smoking as well as no nicotine withdrawal effects during the imaging session (59) .
Subjects were required to perform a visual oddball task. The task has been designed to measure the attentional network brain response (41), which has been previously found to be abnormal in smokers during this particular task conditions (42). We employed an `event-related´ fMRI design with presentation of 160 visual stimuli (40 targets, 120 non-targets, checkerboard reversal) by means of a back-projection system onto a translucent screen using the `Presentation´ software package (Neurobehavioral Systems Inc.®). Subjects were instructed to respond as quickly and accurate as possible to each stimulus by pressing either the left button (non-target) or the right button (target). Stimuli were presented with a duration of 500ms in counter-balanced and pseudorandomized order at `jittered´ inter-stimulus intervals (ISIs) of 6000 ± 500ms between stimulus onsets. The relatively short and pseudorandomized ISIs were chosen because a similar stochastic design was successfully used in a previous fMRI study (60) . As behavioural outcome measure, motor responses (latency, intra-subject variability) were recorded through a fiber optic response box. The total duration of the task was 960s.
MRI scanning
Imaging was conducted with a 1.5T Siemens Sonata® scanner using an 8-channel head coil. In order to avoid head movements, the head of each subject was tightly fixated with cushions during the scanning procedure. To facilitate localization and co-registration of functional data, structural scans were acquired using T1-weighted MRI sequences (Magnetization 
Image analysis
fMRI-analysis was performed with FSL (FMRIB's Software Library, www.fmrib.ox.ac.uk/fsl). After motion artefact correction using the SIEMENS motion correction, the remaining motion artefacts were less than 1mm and therefore, no subject was excluded for excessive motion. The following pre-statistics processing was applied: Employing different modules of the FSL-software package, we conducted motion correction using MCFLIRT (61), non-brain removal using BET (62) 38. Feng, Y., Niu, T., Xing, H., Xu, X., Chen, C., Peng, S., Wang, L., Laird, N., Xu, X. 
